IRVINE, Calif., Nov. 26, 2018 /PRNewswire/ -- BIOLASE,
Inc. (NASDAQ: BIOL), the global leader in dental lasers, today
announced it has been invited to present at the following two
investor conferences in December.
11th Annual LD Micro Main Event
Tuesday, December 4, 2018 at
11:00 a.m. PT (formal presentation
and one-on-one meetings)
Los Angeles
13th Annual Singular Research 'Best of the Uncovered' – Small
Cap
Thursday, December 13,
2018 (formal presentation and one-on-one meetings)
San Francisco
BIOLASE President and CEO Todd
Norbe and Executive Vice President and CFO John Beaver will present and/or host one-on-one
and small group meetings with institutional investors at these
conferences. Meetings can be scheduled through the firms hosting
the conferences or through BIOLASE's investor relations firm, EVC
Group LLC (contact information below).
To access the live webcast or replay of the formal presentation
at the LD Micro conference, visit the investor relations section of
the company's website at www.biolase.com.
About LD Micro
LD Micro was founded in 2006 with the
sole purpose of being an independent resource in the microcap
space. We are investors, first and foremost. What started out as a
newsletter highlighting unique companies has transformed into
several influential conferences annually (Invitational, Summit, and
Main Event). In 2015, LD Micro launched ldmicro.com as a portal to
provide exclusive intraday information on the entire sector,
including the first pure microcap index (LDMi) which covers stocks
in North America with market
capitalizations between $50-$300
million.
About Singular Research
Singular Research aims to
be the most trusted supplier of independent, trusted, single-source
research on small-to-micro cap companies to the small-to-medium
sized Hedge Fund manager. We will provide quarterly updates for 40
to 70 companies and make recommendations. How do we strive to
achieve our Mission / Goal?
- Find under or overvalued securities: Our goal is to provide
initiation reports and quarterly updates for approximately 40 micro
to small cap companies. In most cases, our analysts research
companies that are not covered by any other firms.
- We provide Honest Advice: Our Independent analysts have no
financial interest in the stocks we cover. Analysts are compensated
based on the accuracy of their research calls not through trading
commissions or potential deal flow.
- Track Record: Our picks have gained 299.3% since inception in
2004, compared with a gain of 116.4% for the Russell 2000 and 77.8%
for the S&P 500 over the same period.
About BIOLASE
BIOLASE, Inc. is a medical device
company that develops, manufactures, markets, and sells laser
systems in dentistry and medicine and also markets, sells, and
distributes dental imaging equipment, including three-dimensional
CAD/CAM intra-oral scanners and digital dentistry
software. BIOLASE's products advance the practice of dentistry
and medicine for patients and healthcare
professionals. BIOLASE's proprietary laser products
incorporate approximately 327 patented and 69 patent-pending
technologies designed to provide biologically clinically superior
performance with less pain and faster recovery
times. BIOLASE's innovative products provide
cutting-edge technology at competitive prices to deliver the best
results for dentists and
patients. BIOLASE's principal products are
revolutionary dental laser systems that perform a broad range of
dental procedures, including cosmetic and complex surgical
applications, and a full line of dental imaging
equipment. BIOLASE has sold over 38,100 laser systems to
date in over 90 countries around the world. Laser products under
development address BIOLASE's core dental market and
other adjacent medical and consumer markets.
For updates and information on Waterlase iPlus®, Waterlase
Express™, and laser dentistry, find BIOLASE online
at www.biolase.com, Facebook at www.facebook.com/biolase,
Twitter at www.twitter.com/biolaseinc and LinkedIn
at www.linkedin.com/company/biolase.
BIOLASE®, Waterlase® and Waterlase iPlus® are registered
trademarks of BIOLASE, Inc.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/biolase-announces-schedule-of-investor-conferences-in-december-300755046.html
SOURCE BIOLASE, Inc.